What Is Silexion Therapeutics Corp (SLXN) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, the balance of valuation evidence tilts cautious on Silexion Therapeutics Corp at its current price of $2.54. The composite intrinsic value is estimated at $2.34 (-7.9% average return), with 4 models flagging overvaluation risk. Notably, Dynamic NAV sees the most upside at +110.3% (fair value: $5.34), while ML-RIV is the most conservative at -99.6% ($0.01). The spread between these extremes — +209.8% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About SLXN?
7 of 13 models are currently active for SLXN. Of these, 3 models suggest upside while 4 models suggest overvaluation. The Bayesian DCF estimates SLXN's intrinsic value at $1.59, implying -37.3% downside from the current price. See which stocks rank higher →
How Does SLXN Rank in Biological Products, (No Diagnostic Substances)?
Among 139 Biological Products, (No Diagnostic Substances) stocks, SLXN ranks #62 by Quality of Company score. CirclFi's QOC score of 5.4/10 evaluates 32 fundamental signals. A score of 5.4 reflects mixed fundamentals.
See all Most Undervalued Biological Products, (No Diagnostic Substances) Stocks →
Silexion Therapeutics Corp operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is SLXN a Value Trap?
CirclFi's Value Trap algorithm assigns SLXN a score of 8/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
7 of 13 models are active for Silexion Therapeutics Corp. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Silexion Therapeutics Corp's fundamental quality profile registers 5.4/10. This mixed score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +209.8% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every SLXN valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across SLXN's 7 active models, average confidence is 23%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad